GSK to Cut 650 U.S. Jobs

Sep 07, 2018

GlaxoSmithKline says it plans on cutting about 650 positions in the United States related to a global restructuring program it announced in July.

The cuts will include about 100 each in offices in Philadelphia and at Research Triangle Park, North Carolina, and 450 sales representatives, a spokesperson said.

According to the drugmaker, the savings from these layoffs will help fund increases in R&D and commercial support of new product launches.

Read the Reuters coverage

Want to get content like this in your inbox?  Subscribe to our eNewsletter here!